P. A. Slominsky

16.3k total citations
126 papers, 1.4k citations indexed

About

P. A. Slominsky is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, P. A. Slominsky has authored 126 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 45 papers in Neurology and 44 papers in Cellular and Molecular Neuroscience. Recurrent topics in P. A. Slominsky's work include Parkinson's Disease Mechanisms and Treatments (39 papers), Nuclear Receptors and Signaling (20 papers) and Genetic Neurodegenerative Diseases (16 papers). P. A. Slominsky is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (39 papers), Nuclear Receptors and Signaling (20 papers) and Genetic Neurodegenerative Diseases (16 papers). P. A. Slominsky collaborates with scholars based in Russia, United Kingdom and Ukraine. P. A. Slominsky's co-authors include М. И. Шадрина, Limborskaia Sa, Elena V. Filatova, Elena Bondarenko, С. Н. Иллариошкин, N. F. Myasoedov, Elena D. Markova, I. A. Ivanova‐Smolenskaya, Э. К. Хуснутдинова and M. V. Ugrumov and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

P. A. Slominsky

120 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. A. Slominsky Russia 20 609 377 357 198 195 126 1.4k
М. И. Шадрина Russia 18 519 0.9× 334 0.9× 335 0.9× 106 0.5× 172 0.9× 111 1.2k
Marcin Piechota Poland 22 550 0.9× 445 1.2× 195 0.5× 118 0.6× 185 0.9× 61 1.4k
Sung Won Kim United States 21 678 1.1× 368 1.0× 154 0.4× 189 1.0× 266 1.4× 51 1.9k
Mahesh Kandasamy India 25 538 0.9× 482 1.3× 296 0.8× 74 0.4× 148 0.8× 60 1.6k
Merina Varghese United States 23 707 1.2× 351 0.9× 266 0.7× 258 1.3× 472 2.4× 51 1.8k
Antonella Borreca Italy 17 562 0.9× 313 0.8× 242 0.7× 96 0.5× 317 1.6× 32 1.2k
Zoya Marinova Switzerland 19 1.1k 1.7× 612 1.6× 141 0.4× 263 1.3× 238 1.2× 32 1.8k
Thomas Bettecken Germany 22 786 1.3× 163 0.4× 174 0.5× 379 1.9× 255 1.3× 53 2.0k
Éva M. Szegő Germany 22 670 1.1× 512 1.4× 578 1.6× 164 0.8× 480 2.5× 38 1.8k
Margot Fournier Switzerland 22 837 1.4× 397 1.1× 531 1.5× 92 0.5× 364 1.9× 46 2.1k

Countries citing papers authored by P. A. Slominsky

Since Specialization
Citations

This map shows the geographic impact of P. A. Slominsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. A. Slominsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. A. Slominsky more than expected).

Fields of papers citing papers by P. A. Slominsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. A. Slominsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. A. Slominsky. The network helps show where P. A. Slominsky may publish in the future.

Co-authorship network of co-authors of P. A. Slominsky

This figure shows the co-authorship network connecting the top 25 collaborators of P. A. Slominsky. A scholar is included among the top collaborators of P. A. Slominsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. A. Slominsky. P. A. Slominsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Filatova, Elena V., et al.. (2023). Differential expression of Dusp1 and immediate early response genes in the hippocampus of rats, subjected to forced swim test. Scientific Reports. 13(1). 9985–9985. 2 indexed citations
3.
Шадрина, М. И. & P. A. Slominsky. (2023). Genetic Architecture of Parkinson’s Disease. Biochemistry (Moscow). 88(3). 417–433. 6 indexed citations
4.
Шадрина, М. И. & P. A. Slominsky. (2023). Genetic architecture of Parkinson’s disease. 88(3). 508–527. 1 indexed citations
6.
Usenko, Tatiana, Михаил Николаев, И. В. Шлык, et al.. (2023). Fraction of plasma exomeres and low-density lipoprotein cholesterol as a predictor of fatal outcome of COVID-19. PLoS ONE. 18(2). e0278083–e0278083. 2 indexed citations
7.
Fedotova, E. Yu., et al.. (2023). Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson’s Disease. BioMed Research International. 2023(1). 9412776–9412776. 2 indexed citations
9.
Шадрина, М. И. & P. A. Slominsky. (2021). Modeling Parkinson’s Disease: Not Only Rodents?. Frontiers in Aging Neuroscience. 13. 695718–695718. 13 indexed citations
10.
Fedotova, E. Yu., Tatiana Usenko, Anton Emelyanov, et al.. (2018). Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson’s Disease. Frontiers in Aging Neuroscience. 10. 136–136. 17 indexed citations
11.
Дорохов, В. Б., et al.. (2017). [Polymorphisms in Sleep and Cognitive Function Related Genes are Associated with Vehicle Crash History in Shift Working Bus Drivers].. PubMed. 67(1). 49–54. 1 indexed citations
12.
Bondarenko, Elena, et al.. (2017). Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology. 2017. 1–6. 6 indexed citations
13.
Сивков, А.В., et al.. (2016). [Genetic risk factors for recurrence-free urolithiasis in the russian population].. PubMed. 20–23. 1 indexed citations
14.
Bondarenko, Elena, et al.. (2016). Genetic Analysis of BDNF, GNB3, MTHFR, ACE and APOE Variants in Major and Recurrent Depressive Disorders in Russia. International Journal of Medical Sciences. 13(12). 977–983. 13 indexed citations
15.
Шадрина, М. И., et al.. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. 7. 31–31. 10 indexed citations
16.
Шадрина, М. И., et al.. (2011). Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease. Movement Disorders. 27(1). 139–143. 8 indexed citations
17.
Иллариошкин, С. Н., et al.. (2007). Heterogeneity of sporadic Parkinson’s disease: molecular approach to solving the problem. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Sa, Limborskaia, P. A. Slominsky, Elena Balanovska, et al.. (2004). East European lowland as an area of long-time interaction between Caucasoid and Mongoloid peoples. Human Evolution. 19(3). 203–215.
19.
Скворцова, В. И., et al.. (2001). Sporadic ALS associated with the D90A Cu,Zn superoxide dismutase mutation in Russia. European Journal of Neurology. 8(2). 167–172. 23 indexed citations
20.
Иллариошкин, С. Н., Elena D. Markova, P. A. Slominsky, et al.. (1998). The GTP Cyclohydrolase I Gene in Russian Families With Dopa-Responsive Dystonia. Archives of Neurology. 55(6). 789–789. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026